A clinical study of ovarian tumors and assessment of risk of malignancy by RMI and correlation with histopathological examination

  • Gayatri koyya Assistant Professor, Department of Obstetrics and Gynecology, GSL Medical College, Rajahmundry, Andhra Pradesh, India
  • Sowjanya Moturi Assistant Professor, Department of Obstetrics and Gynecology, GSL Medical College, Rajahmundry, Andhra Pradesh, India
  • T Jaya Chandra Professor, Department of Microbiology, GSL Medical College, Rajahmundry, Andhra Pradesh, India
Keywords: Ovarian tumors, tumors, score, women

Abstract

Introduction: Ovarian tumors (OTs) are one of the major gynaecological diseases. Risk of Malignancy Index (RMI) score is used to evaluate the OTs. A study was considered to correlate the clinical study of OTs and assessment of RMI scoring.

Materials and methods: It was a prospective study conducted in the department of Obstetrics and Gynecology, Mamata Medical College, Khammam. Women aged > 18 years, diagnosed with OTs >6cm in size were included. Women with unilateral, unilocular, thin-walled cysts with regular borders and <6cms were not considered. Menopausal (M) score was assigned by considering the age and menstrual history. USG abdomen and pelvis with 3.5 HZ abdominal convex transducers was carried along with radiologist support to determine the tumour size. USG score was given accordingly depending upon the number of variables that were present. Histopathological diagnosis was considered as the standard for determining the diagnostic value of the RMI index. The Chi-square test was considered for categorical data. P>0.005 was taken as statistically significant.

Results: OTs were more common between the 21 – 50 years group. The OTs were more commonly seen in parous women with para 2, para 3 and the above groups. Epithelial tumors were the highest (88.57%). The incidence of MTs was increased with the ultrasound score.

Conclusion: Tumors occur in all age groups in multiparous women and major cases in 31 – 40 years. The RMI scoring was better in diagnosing the OTs and histopathological examination is still the gold standard.

Downloads

Download data is not yet available.

References

1. Civenlee RT. Elarmon Mll, Murray T, et al. Cancer statistics 2001 CA Cancer. J Clin, 2001; 51: 15 – 36.
2. Janobs B, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomized controlled trial. Lancet 1999; 353: 1207 – 10. doi: 10.1016/S0140-6736(98)10261-1
3. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporatis CA 125, ultrasound and menopausal status for the accurate preoperati diagnosis of ovarian cancer.Br J Obstet Gynaccol 1990; 97: 922 – 9. DOI: 10.1111/j.1471-0528.1990.tb02448.x
4. Tahereh Ashrafgangooei, Mahdieh Rezzaeezadeh. Risk off malignancy index in preoperative evaluation of pelvic masses. Asian Pac J Cancer Prev 2011; 12: 1727 – 30. PMID: 22126553
5. Ulusoy S, Akbayir O, Numanoglu C, et al. The risk of malignancy index in discrimination of adnexal masses. Int J Gynaecol Obstet. 2007; 96: 186 – 91. doi: 10.1016/j.ijgo.2006.10.006
6. Chakraborthi DK, Sandra Lee CM. Epidemiological study of ovarian neoplasm. J Obstet Gynaec India 1990; 40(4): 582 – 6. doi: 10.20892/j.issn.2095-3941.2016.0084
7. Petronella AJ, Van den Akker, et al. Evaluation of the risk of malignancy index in daily clinical management of adnexal masses. Gynecol Oncol 2010; 116(3): 384 – 88.
8. Yuen PM, Yu KM, Yip SK, et al. A randomized prospective study of 55. laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol, 1997; 177: 109 – 14.
9. Jadhav Balaji Jagannath, Shinde Mangala Ashok. Ovarian germ cell tumors, 5 years study. Obstet Gynecol India 2005; 55(1): 612 – 63.
10. Andersen ES, Knudsen A, Rix P, et al. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol. 2003; 90: 109 – 12.
11. Moolthiya W, Yuenyao P. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy. Asian Pac J Cancer Prev 2009; 10(5): 865 – 8.
12. Manjunath AP, Pratapkumar AP, Sujatha K, et al. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol. 2001; 81: 225 – 9.
13. Morgante G, la Marca A, Ditto A, et al. Comparison of two malignancy indices based on serum CA 125 ultrasound score and menopausal status in uie diagnosis of ovarian masses. Br J Obstet Gynaecol. 1999; 106: 524 – 7.
14. Davies AP, Jacobs I, Woolas R, Fish A.Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol. 1993; 100: 927 – 31.
How to Cite
Gayatri koyya, Sowjanya Moturi, & T Jaya Chandra. (2022). A clinical study of ovarian tumors and assessment of risk of malignancy by RMI and correlation with histopathological examination . Obs Gyne Review: Journal of Obstetric and Gynecology, 7(6), 71-75. Retrieved from https://obstetrics.medresearch.in/index.php/joog/article/view/149
Issue
Vol 7 No 6 (2021): NOV-DEC
Section
Original Article

Copyright (c) 2022 Author (s). Published by Siddharth Health Research and Social Welfare Society

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.